MedWatch

NNE capitalizes on new generation of drug factories

New possibilities help NNE Pharmaplan to continue its rapid growth in China, but the market also poses a number of challenges. Materials for pharmaceutical factories are not always what they seem, for example.

Foto: NNE Pharmaplan

Danish company NNE Pharmaplan is going to get a piece of the pie from the colossal growth in China. The company, which specializes in designing and building factories for drug manufacturing, is seeing growth rates of up to 20 % per year, and it looks like it will carry on for some time.

Whereas Western pharmaceutical groups have established one medicine packaging plant after the other in the past, the tendency is shifting towards more advanced factories.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier